Vanda Pharmaceuticals
VNDA
#7861
Rank
NZ$0.55 B
Marketcap
NZ$9.33
Share price
3.65%
Change (1 day)
14.82%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$1.04 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's total assets are NZ$1.04 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Vanda Pharmaceuticals - Total assets on balance sheet (from 2005 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$1.16 B13.48%
2023-12-31NZ$1.02 B2.64%
2022-12-31NZ$0.99 B14.91%
2021-12-31NZ$0.86 B17.58%
2020-12-31NZ$0.73 B2.93%
2019-12-31NZ$0.71 B45.06%
2018-12-31NZ$0.49 B71.18%
2017-12-31NZ$0.28 B-4.76%
2016-12-31NZ$0.30 B-2.44%
2015-12-31NZ$0.31 B42.05%
2014-12-31NZ$0.21 B25.63%
2013-12-31NZ$0.17 B5.95%
2012-12-31NZ$0.16 B-29.63%
2011-12-31NZ$0.23 B-15.29%
2010-12-31NZ$0.27 B-11.12%
2009-12-31NZ$0.31 B261.16%
2008-12-31NZ$86.04 M-31.95%
2007-12-31NZ$0.12 B145.68%
2006-12-31NZ$51.46 M-1.6%
2005-12-31NZ$52.3 M110.25%
2004-12-31NZ$24.87 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
NZ$185.71 B 17,747.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$198.95 B 19,019.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$333.76 B 31,975.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$167.71 B 16,017.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$361.31 B 34,622.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ$5.28 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$224.24 B 21,450.05%๐Ÿ‡บ๐Ÿ‡ธ USA